AANP Molecular Neuropathology Course 

Registration Link: https://aanp.memberclicks.net/molecularneuropath

Session Access: www.pathlms.com/aanp 

Please Note: There is a delay between registering for the activity and receiving access to the series in Path LMS, the learning management system. 

The American Association of Neuropathologists Molecular Neuropathology Course: Central Nervous System Tumors regularly scheduled series has ended. However, while the live sessions have passed, registrants can still obtain access to the recorded content through 9/30/2025. CME credit is not available. Once registered, an AANP representative will send you separate instructions for accessing this activity via Path LMS. Leomar Ballester, MD, PhD, MD Anderson Cancer Center, and Cristiane Ida, MD, Mayo Clinic, are the Co-Course Directors.

The cost is as follows:
  • AANP Members: $50.00
  • AMP Members: $50.00
    • Discount Code required; code sent to all AMP members. Reach out to [email protected] with questions.
  • Non-Members: $100.00
  • All Trainees (AANP Members and Non-Members): $0.00

Please note that only the live session is accredited for CME; credit may not be claimed for watching the recording. 

Certificate of Completion: Following the in-person course in Minneapolis on June 18, 2025, an overall evaluation will be disseminated to all Molecular Neuropathology Course attendees – whether an individual solely attended the regularly scheduled series sessions August through May and/or the in-person ancillary meeting. The overall evaluation will require attendees to attest to whether they attended or watched at least 8 of the 10 sessions that occurred between August 2024 and May 2025. With this self-attestation, individuals who attended (or watched) 8/10 sessions will be issued a Certificate of Completion electronically. Given the evaluation will remain open through 9/30/2025, certificates will be issued in October 2025. 

List of Resources: Please click here for a list of resources.

2024/2025 Schedule

Date Presenter Topic
Monday, August 12, 2024 Leomar Ballester, MD, PhD, MD Anderson Cancer Center and Cris Ida, MD, Mayo Clinic
Molecular Basics Overview
Tuesday, September 10, 2024 Kandelaria (Ande) Rumilla, MD, Mayo Clinic
Preanalytical Factors in Molecular Testing
Monday, October 14, 2024 Kevin Fisher, MD, PhD, Baylor College of Medicine
Sequencing Testing Platforms
Tuesday, November 12, 2024 Richard Yang, MD, PhD, MD Anderson Cancer Center
Next-Generation Sequencing
Monday, December 9, 2024 Stewart Neill, MD, MS, Emory University School of Medicine Copy Number Testing
Tuesday, January 14, 2025 Beth Pitel, MS, Mayo Clinic Variant Classification/Databases
Monday, February 10, 2025 Brent Orr, MD, PhD, St. Jude Children’s Research Hospital Hereditary Implications in Molecular Testing
Tuesday, March 11, 2025 Lawrence Jennings, MD, PhD, Northwestern University Methylation Profiling
Monday, April 14, 2025 Leomar Ballester, MD, PhD, MD Anderson Cancer Center Liquid Biopsy
Tuesday, May 13, 2025 Cristiane Ida, MD, Mayo Clinic

MGMT Promoter Methylation Testing

 

2025 Ancillary Meeting

In addition to the regularly scheduled series, there will be an in-person Molecular Neuropathology Course: CNS Tumors pre-conference symposium at the AANP 101st Annual Meeting in Minneapolis. Annual Meeting registrants may register for and attend the symposium at no additional charge. Registrants of the regularly scheduled series will receive the audio/slide recording regardless of whether or not they are able to attend the symposium in person. More information regarding the in-person course will be announced in conjunction with registration launch for the 101st Annual Meeting in Q4 2024. Please note: Registration for this in-person course is separate from registration for the regularly scheduled series. 

 Accreditation Information

Overall Learning Objectives:
  1. Explain how to select appropriate molecular tests and interpret the results.
  2. Recognize diagnostically relevant molecular biomarkers.
  3. Describe clinicopathologic scenarios that require molecular biomarker testing.
  4. Discuss technical aspects of various molecular testing platforms including next-generation sequencing, genome-wide chromosomal microarray, and global DNA methylation analysis.
  5. Explain how to interpret molecular test results and generate integrated histo-molecular diagnosis for CNS tumors.

Accreditation Statement: The American Association of Neuropathologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation: The American Association of Neuropathologists designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please contact the American Association of Neuropathologists at (720) 372-0888.